BPMX Research and Charts

BPMX - BioPharmX Corp (Healthcare: Biotechnology)

Projected Earnings Date: 2019-09-10 (Delayed quote data )

Last	Change ⇓ 0.00 (%)	Volume 0
	Open	High	Low

8EMA (Daily) 0.00	40EMA (Daily)	50EMA (Daily)	STO (Daily)	MACD Hist (Daily)
8EMA (Weekly) 1.953	40EMA (Weekly) 2.04	50EMA (Weekly) 1.94	STO (Weekly) 39.977	MACD Hist (Weekly) -0.495


Company Profile
BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated or are currently treated with drug therapies or drug delivery approaches that are sub-optimal. The company has developed its product portfolio using its proprietary drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. Its products include VI2OLET iodine dietary supplement, two clinical-stage product candidates, BPX01 and BPX03 and one development-stage product candidate, BPX02.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.